PHIBRO ANIMAL HEALTH CORP
About PHIBRO ANIMAL HEALTH CORP
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.3B
- Net income
- $48.3M
- Total assets
- $1.4B
- Market cap
- $1.3B
- Gross margin
- 30.9%
- Operating margin
- 8.5%
- Net margin
- 3.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.3B
- Cost of revenue
- $896.3M
- Gross profit
- $399.9M
- Operating expenses
- $289.5M
- Operating income
- $110.5M
- Income tax
- $19.7M
- Net income
- $48.3M
- EPS (basic)
- $1.19
- EPS (diluted)
- $1.19
Balance sheet
- Total assets
- $1.4B
- Current assets
- $810.6M
- Total liabilities
- $1.1B
- Current liabilities
- $293.5M
- Shareholders’ equity
- $285.7M
Cash flow
- Operating cash flow
- $80.1M
- Investing cash flow
- -$288.7M
- Financing cash flow
- $207.1M
- Net cash flow
- -$2.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $1.3B
- P/E ratio
- 26.7
- EPS (diluted)
- $1.19
- Dividend yield
- 1.51%
- Shares outstanding
- 41.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 11, 2014
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $48.3M in FY2025.
- Revenue grew 56% from FY2021 to FY2025.
- Gross margin of 30.9%, net margin 3.7%.
- Trading 47% below its 52-week high.
- Pays a dividend yielding about 1.51% annually.
- Valued at a price-to-earnings (P/E) ratio of 26.7.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PHIBRO ANIMAL HEALTH CORP.
Write a review
News about PHIBRO ANIMAL HEALTH CORP
News & sentiment via Polygon.io
